Variant report
Variant | esv3329294 |
---|---|
Chromosome Location | chr6:34011799-34012374 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:34011747..34013677-chr6:34019752..34021828,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372575035 | chr6:34011809-34011810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs35269977 | chr6:34011825-34011826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537162522 | chr6:34011826-34011827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78021705 | chr6:34011834-34011835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201484727 | chr6:34011843-34011844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139572683 | chr6:34011854-34011855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536423212 | chr6:34011855-34011856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113369768 | chr6:34011869-34011870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201310081 | chr6:34011897-34011898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576524945 | chr6:34011903-34011904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs71678350 | chr6:34011910-34011911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540865064 | chr6:34011928-34011929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138369188 | chr6:34011934-34011935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs541838412 | chr6:34011939-34011940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531019999 | chr6:34011941-34011942 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10947474 | chr6:34011945-34011946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541729867 | chr6:34011947-34011948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561348957 | chr6:34011951-34011952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531566963 | chr6:34011963-34011964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs149560301 | chr6:34011964-34011965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565420383 | chr6:34011968-34011969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200421962 | chr6:34011969-34011970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532636972 | chr6:34011970-34011971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370976999 | chr6:34011975-34011976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533677306 | chr6:34011977-34011978 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs548040731 | chr6:34011978-34011979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13194353 | chr6:34011981-34011982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566250548 | chr6:34011984-34011985 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13194357 | chr6:34011987-34011988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530441080 | chr6:34011988-34011989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548563032 | chr6:34011992-34011993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200437645 | chr6:34012002-34012003 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
33 | rs13194361 | chr6:34012003-34012004 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201679393 | chr6:34012005-34012006 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537542251 | chr6:34012007-34012008 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs375229312 | chr6:34012024-34012025 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs199711307 | chr6:34012026-34012027 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558512852 | chr6:34012028-34012029 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570245756 | chr6:34012042-34012043 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200834298 | chr6:34012048-34012049 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552769329 | chr6:34012054-34012055 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs200206367 | chr6:34012063-34012064 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs574257335 | chr6:34012066-34012067 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542117059 | chr6:34012080-34012081 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557021022 | chr6:34012103-34012104 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201121660 | chr6:34012139-34012140 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368038250 | chr6:34012140-34012141 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
48 | rs575485340 | chr6:34012148-34012149 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
49 | rs199557202 | chr6:34012150-34012151 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
50 | rs540171375 | chr6:34012151-34012152 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:33984400-34023000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr6:33988000-34013600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr6:33994400-34013000 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr6:34000200-34016000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
5 | chr6:34002800-34027000 | Weak transcription | Spleen | Spleen |
6 | chr6:34004000-34013400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr6:34004200-34013400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr6:34004400-34013400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr6:34010400-34013000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr6:34010400-34013000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr6:34010400-34013400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
12 | chr6:34010600-34012000 | Weak transcription | GM12878-XiMat | blood |
13 | chr6:34011600-34013600 | Weak transcription | Brain Anterior Caudate | brain |
14 | chr6:34011800-34012000 | Enhancers | Fetal Kidney | kidney |
15 | chr6:34012000-34012800 | Bivalent Enhancer | Fetal Brain Male | brain |
16 | chr6:34012000-34012800 | Bivalent Enhancer | Fetal Kidney | kidney |